Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/17/2010 | US20100154074 Nucleic Acids and Proteins Associated with Sucrose Degradation in Coffee |
06/17/2010 | US20100154073 Dehydrin Genes and Promoters From Coffee |
06/17/2010 | US20100154072 siRNA Kinase and Methods of Use |
06/17/2010 | US20100154071 Fxdy5 modulators for treating, diagnosing, and detecting cancer |
06/17/2010 | US20100154070 PiggyBac as a Tool for Genetic Manipulation and Analysis in Vertebrates |
06/17/2010 | US20100154069 Pig model |
06/17/2010 | US20100152419 Fusion protein containing highly-expressed and secreted insulin precursor, dna encoding same, and method of producing insulin |
06/17/2010 | US20100152282 Use of double stranded rna hairpin duplexes in gene silencing |
06/17/2010 | US20100152281 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function |
06/17/2010 | US20100152279 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma |
06/17/2010 | US20100152278 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
06/17/2010 | US20100152212 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
06/17/2010 | US20100152113 Metal-binding therapeutic peptides |
06/17/2010 | US20100152092 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains; expression vectors, recombinant host cells |
06/17/2010 | US20100152064 siRNA targeting BCL2L1 |
06/17/2010 | US20100152059 Method for screening biomolecules |
06/17/2010 | US20100152051 Novel method for the identification of clones conferring a desired biological property from an expression library |
06/17/2010 | US20100151590 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
06/17/2010 | US20100151589 Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof |
06/17/2010 | US20100151576 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
06/17/2010 | US20100151572 Anti-tumoral compositions methods |
06/17/2010 | US20100151567 Nucleic Acids Useful in the Manufacture of Oil |
06/17/2010 | US20100151566 Recombinant antibodies against the vascular endothelial growth factor (vegf) |
06/17/2010 | US20100151556 Hybrid and single chain meganucleases and use thereof |
06/17/2010 | US20100151555 Isoprenoid compounds |
06/17/2010 | US20100151548 vector with codon-optimised genes for an arabinose metabolic pathway for arabinose conversion in yeast for ethanol production |
06/17/2010 | US20100151537 Modified ethylenediamine-n, n'-disuccinate: ethylenediamine lyase |
06/17/2010 | US20100151534 Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
06/17/2010 | US20100151532 Chondroitin-producing bacterium and method of producing chondroitin |
06/17/2010 | US20100151530 Method for producing plasmid dna on a manufacturing scale |
06/17/2010 | US20100151529 Engineered phosphite dehydrogenase mutants |
06/17/2010 | US20100151528 Methods of producing validamycin a analogs and uses thereof |
06/17/2010 | US20100151524 Compositions and Methods for Increasing Bone Mineralization |
06/17/2010 | US20100151523 Regulated expression of recombinant proteins from adeno-associated viral vectors |
06/17/2010 | US20100151522 Process For Producing Recombinant Fibrinogen Highly Producing Cell and Highly Producing Cell |
06/17/2010 | US20100151521 Method for Stable Gene-Amplification in a Bacterial Host Cell |
06/17/2010 | US20100151520 Translation Enhancer Elements Of Genes Encoding Human Tau Protein and Human Alpha-Synuclein Protein |
06/17/2010 | US20100151518 Vectors and methods for enzyme production |
06/17/2010 | US20100151516 Gene SMS 13 |
06/17/2010 | US20100151502 Functional expression of triacylgylcerol lipases |
06/17/2010 | US20100151496 Assays for nuclear hormone receptor binding |
06/17/2010 | US20100151486 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
06/17/2010 | US20100151478 Methods for disease detection |
06/17/2010 | US20100151477 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences |
06/17/2010 | US20100151476 Phenylthiocarbamide (ptc) taste receptor |
06/17/2010 | US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna |
06/17/2010 | US20100151452 Methods and Systems for Searching for Regulators of the Fer Protein and for Monitoring the Effects of the Fer Protein |
06/17/2010 | US20100151449 Method for poduction of l-amino acids by fermentation |
06/17/2010 | US20100151111 Polypeptides of Strain Bacillus SP. P203 |
06/17/2010 | US20100151109 Modulation of plant protein levels |
06/17/2010 | US20100151097 Optimization of colicin production |
06/17/2010 | US20100151051 Anti-tumor drug, medicament, composition, and use thereof |
06/17/2010 | US20100151002 Guggulphospholipid Methods and Compositions |
06/17/2010 | US20100150998 Vaccines for malaria |
06/17/2010 | US20100150968 Dna vectors |
06/17/2010 | US20100150962 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
06/17/2010 | US20100150959 PCV 2-Based Methods and Compositions for the Treatment of Pigs |
06/17/2010 | US20100150958 Methods and Compositions for Use of a Coccidiosis Vaccine |
06/17/2010 | US20100150945 Anti-mdl-1 antibodies |
06/17/2010 | US20100150940 Anti-igf antibodies |
06/17/2010 | US20100150937 Antagonists of pcsk9 |
06/17/2010 | US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker |
06/17/2010 | US20100150926 Fusion protein capable of binding vegf-a and tnf-alpha |
06/17/2010 | US20100150924 Regulation of myelination by nectin-like (necl) molecules |
06/17/2010 | US20100150923 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
06/17/2010 | US20100150918 Cross-species-specific binding domain |
06/17/2010 | US20100150916 huTNFR1 Selective Antagonists |
06/17/2010 | US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION |
06/17/2010 | US20100150902 Anti-cd151 antibodies and their use in the treatment of cancer |
06/17/2010 | US20100150889 Polycistronic Vector For Human Induced Pluripotent Stem Cell Production |
06/17/2010 | US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
06/17/2010 | US20100150860 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof |
06/17/2010 | US20100150841 Use of Tumor Necrosis Factor-Alpha P75 Receptor for the Reduction of Inflammation |
06/17/2010 | US20100150835 Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate |
06/17/2010 | DE102008063234A1 Biotechnologische Herstellung von Riboflavin mit hoher Ausbeute Biotechnological production of riboflavin with high yield |
06/17/2010 | DE102008061714A1 Verfahren zur Aufreinigung von Nukleinsäuren, inbesondere aus fixiertem Gewebe A method for purifying nucleic acids, in particular from fixed tissue |
06/17/2010 | DE102008061522A1 Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung Use of Flt3-ligand for the reinforcement of immune responses in RNA-immunization |
06/17/2010 | DE102008060844A1 Antimikrobielle Peptide aus Hydra Antimicrobial peptides from Hydra |
06/17/2010 | DE102008054494A1 New nucleic acid encoding a fusion protein that comprises specific amino acid sequences and a matrix-metalloprotease |
06/17/2010 | CA2747127A1 Process for the enzymatic production of cyclic diguanosine monophosphate employing a diguanylate cyclase comprising a mutated rxxd motif |
06/17/2010 | CA2746632A1 Classification of nucleic acid templates |
06/17/2010 | CA2746514A1 Gnaq targeted dsrna compositions and methods for inhibiting expression |
06/17/2010 | CA2746504A1 Method for producing sugar liquid |
06/17/2010 | CA2746489A1 Method for purification of nucleic acids, particularly from fixed tissue |
06/17/2010 | CA2746441A1 Production of branched-chain alcohols by photosynthetic microoraganisms |
06/17/2010 | CA2746339A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms |
06/17/2010 | CA2746196A1 Transformation of sugar cane |
06/17/2010 | CA2746103A1 Screening method for identifying genes involved in plant cell cycle |
06/17/2010 | CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
06/17/2010 | CA2744959A1 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups |
06/17/2010 | CA2744939A1 Plant root-specific nematode resistance |
06/17/2010 | CA2744938A1 Modification of nucleic acid vectors |
06/17/2010 | CA2744930A1 Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms |
06/17/2010 | CA2744004A1 Compositions and methods for detecting small rnas, and uses thereof |
06/17/2010 | CA2688804A1 Polycistronic vector for human induced pluripotent stem cell production |
06/16/2010 | EP2196799A2 Buffers for electrophoresis and use thereof |
06/16/2010 | EP2196541A1 Anti-glypican-3 antibody having improved kinetics in plasma |
06/16/2010 | EP2196540A2 Combinatorial DNA library for producing modified N-Glycans in lower eukaryotes |
06/16/2010 | EP2196537A1 Method for synthesis of single- or double-stranded dna, and kit for the synthesis |
06/16/2010 | EP2196536A1 Methods for production of proteins |